Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 2/20 | 0.32 |
| ▸ | LDHB | P07195 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | PRNP | P04156 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014064 | 1.00 | ALDH1A1 (0.36) | ALDH1A1FFAR3HSD17B10LDHALDHB | |
| SCHEMBL1009054 | 0.94 | ALDH1A1 (0.39) | ALDH1A1FFAR3HSD17B10LDHALDHB | |
| SCHEMBL8573447 | 0.94 | ALDH1A1 (0.39) | ALDH1A1FFAR3HSD17B10LDHALDHB | |
| SCHEMBL29150788 | 0.92 | ALDH1A1 (0.37) | ALDH1A1FFAR3HSD17B10LDHALDHB | |
| SCHEMBL14989322 | 0.89 | ALDH1A1 (0.36) | ALDH1A1FFAR3HSD17B10LDHALDHB | |
| SCHEMBL29180339 | 0.81 | ALDH1A1 (0.38) | ALDH1A1HSD17B10LDHALDHBCYP1A2 | |
| SCHEMBL8196274 | 0.80 | ALDH1A1 (0.35) | ALDH1A1HSD17B10LDHALDHBCYP1A2 | |
| SCHEMBL28939249 | 0.79 | ALDH1A1 (0.37) | ALDH1A1HSD17B10LDHALDHBPTPN1 | |
| SCHEMBL27932259 | 0.79 | ALDH1A1 (0.37) | ALDH1A1HSD17B10LDHALDHBCYP1A2 | |
| SCHEMBL29489493 | 0.77 | LDHA (0.44) | ALDH1A1HSD17B10LDHALDHBPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744863-A1 | CELLULOSE ESTER RESIN COMPOSITION, SHAPED ARTICLE, AND METHODS FOR PRODUCING SAME | Daicel Corporation (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132272-A1 | CELLULOSE ESTER RESIN COMPOSITION, SHAPED ARTICLE, AND METHODS FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2026-05-14 | — | — | US | disclosed |
| US-11414534-B2 | Multifunctional optically highly transparent films and method for their production | ISLAND POLYMER INDUSTRIES GMBH (DE) | 2022-08-16 | — | — | US | disclosed |
| US-11384222-B2 | Composition for polyester hydrolytic stabilization | CLARIANT PLASTICS & COATINGS LTD (CH) | 2022-07-12 | — | — | US | disclosed |
| EP-3313918-B1 | HIGHLY TRANSPARENT COATED CELLULOSETRIACETATE FILM | ISLAND POLYMER IND GMBH (DE) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132272-A1 | CELLULOSE ESTER RESIN COMPOSITION, SHAPED ARTICLE, AND METHODS FOR PRODUCING SAME | FGF1, FGFR4, FGF2 | ALDH1A1 1505/4885FFAR3 887/4885HSD17B10 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.